167 related articles for article (PubMed ID: 5511166)
1. Lymphadenopathy resulting from long-term use of hydantoin.
Szegedi G; Krasznai G; Sorszegi P; Szabó G
Acta Med Acad Sci Hung; 1970; 27(3):243-51. PubMed ID: 5511166
[No Abstract] [Full Text] [Related]
2. Hydantoin lymphadenopathy.
Krasznai G; Györy G
J Pathol Bacteriol; 1968 Jan; 95(1):314-7. PubMed ID: 5643463
[No Abstract] [Full Text] [Related]
3. Systemic lupus erythematosus caused by hydantoin preparations.
Szegedi G; Petrányi G
Ann Immunol Hung; 1972; 16(0):433-44. PubMed ID: 4607152
[No Abstract] [Full Text] [Related]
4. [Hydantoin-induced lymphadenopathy].
Celikic S
Srp Arh Celok Lek; 1973 Feb; 101(2):173-7. PubMed ID: 4207031
[No Abstract] [Full Text] [Related]
5. [Reticular hyperplasia following hydantoin derivatives].
Wasik F; Domanasiewicz M; Gasior B
Hautarzt; 1975 May; 26(5):273-5. PubMed ID: 125251
[No Abstract] [Full Text] [Related]
6. [Generalised follicular lymphadenopathy following primidone therapy: case report (author's transl)].
Flachsbart F; Wilhelms E
Nervenarzt; 1982 May; 53(5):297-8. PubMed ID: 6808404
[No Abstract] [Full Text] [Related]
7. Lymphangiographic findings of mesantoin-induced pseudolymphoma.
Sayoc AS; Howland WJ
Radiology; 1974 Jun; 111(3):579-80. PubMed ID: 4828990
[No Abstract] [Full Text] [Related]
8. Generalized lymphadenopathy and nephrotic syndrome as a manifestation of mephenytoin (mesantoin) toxicity.
Snead C; Siegel N; Hayslett J
Pediatrics; 1976 Jan; 57(1):98-101. PubMed ID: 1246508
[TBL] [Abstract][Full Text] [Related]
9. [Malignant lymphoma or hydantoin lymphadenopathy? (author's transl)].
Beil E; Prechtel K
Munch Med Wochenschr; 1973 Nov; 115(45):2033-9. PubMed ID: 4589193
[No Abstract] [Full Text] [Related]
10. Hydantoin-induced pseudo-pseudolymphoma.
Gams RA; Neal JA; Conrad FG
Ann Intern Med; 1968 Sep; 69(3):557-68. PubMed ID: 4970555
[No Abstract] [Full Text] [Related]
11. [Iatrogenic lymph node lesions (author's transl)].
Leder LD; Lennert K
Verh Dtsch Ges Pathol; 1972; 56():310-20. PubMed ID: 4130833
[No Abstract] [Full Text] [Related]
12. [Malignant lymphoma following years of hydantoin treatment for epilepsy].
Jungi WF; Senn HJ; Stanisic M; Rösli R
Schweiz Med Wochenschr; 1975 Dec; 105(50):1735-7. PubMed ID: 1215968
[TBL] [Abstract][Full Text] [Related]
13. Generalized lymphadenopathy as a drug reaction to hydantoin.
Björnberg A; Holst R
Acta Neurol Scand; 1967; 43(3):399-402. PubMed ID: 4227819
[No Abstract] [Full Text] [Related]
14. [Sperm analysis of patients after long term use of hydantoin].
Schramm P; Seyfeddinipur N
Andrologia; 1980; 12(1):97-101. PubMed ID: 6769360
[TBL] [Abstract][Full Text] [Related]
15. [Synopsis of the hydantoins].
Gottwald W
Fortschr Neurol Psychiatr Grenzgeb; 1969 Nov; 37(11):573-648. PubMed ID: 4901428
[No Abstract] [Full Text] [Related]
16. Hydantoin induced lymphadenopathy. A case of report.
Murthy JM; Chopra JS; Gupta R; Sehgal S; Mohanty D
Neurol India; 1978 Mar; 26(1):38-40. PubMed ID: 683424
[No Abstract] [Full Text] [Related]
17. [Dermatologic complications during the administration of hydantoin compounds (review)].
Gottwald W
Z Haut Geschlechtskr; 1969 Jul; 44(13):471-90. PubMed ID: 4243325
[No Abstract] [Full Text] [Related]
18. Lymphadenopathy associated with diphenylhydantoin therapy.
Abratt RP; Sealy R; Uys CJ; Lawson R
Clin Oncol; 1982 Dec; 8(4):351-6. PubMed ID: 7168928
[No Abstract] [Full Text] [Related]
19. [Fetal diseases due to hydantoin. Description of a case].
Nicoletti I; Mariotti G; Filipponi P; Serena Lungarotti M
Minerva Pediatr; 1980 Jan; 32(1):61-4. PubMed ID: 6789050
[No Abstract] [Full Text] [Related]
20. [Pseudo-lymphomas and lymphomas induced by hydantoins].
Reiffers J
Nouv Rev Fr Hematol (1978); 1978 Apr; 20(1):131-7. PubMed ID: 353727
[No Abstract] [Full Text] [Related]
[Next] [New Search]
